ARCHIVES

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | March 16, 2007

Download PDF Visit The Full Archive

Related Articles

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

September 29, 2006

Also in this 8-page issue: NIH opens 240-bed Hatfield Clinical Research Center.

September 24, 2004

Only 20% of Doctors Advise CRC According To Guidelines

October 29, 2010

In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly

November 17, 1989

HEW Says Patent Delays Temporary

August 25, 1978

Centers See Trend To Integrate Control Service With Science

February 18, 1983